The outrage with the outcomes is the only way a society to addressing the question of the appropriateness of the structures which produce the outcomes. That it is a natural outcome of the existing structure doesn't mean that it isn't absurd, though it might mean that if it is absurd, it is only because the structure of which it is a natural consequence is also absurd.
If the price increase had been negotiated, or given fair warning, or was tied to any documentation of the cost of production, it would be much more tolerable - or at least understandable.
Instead, this follows a recent trend of exploiting sick people for profit through mind-boggling price increases for critical medications after sometimes decades of very low prices. There is most certainly not a 2000% increase in the cost of production - if there were, there would likely be a lot more transparency.
"Will they pay, even if we raise the price by 20x?"
That's not the kind of behavior I'd like to look back on for my own life, when I'm at the end of my days.
It's a nice platitude, but it's obviously untrue. The unstated implication is that a human life actually has infinite value, which is even more obviously untrue.
It's easy to find an upper bound on the value of a human life; would you be willing to pay ten trillion dollars of public money (which would otherwise be hypothetically used to finance schools, research, etc.) to save the life of a single child?
Agreed. For me, that "more information" includes things like: whether or not the drug is viable at its former price, the likelihood of this price driving other entrants into the market to find new solutions to address this problem, the ability of other manufacturers to develop substitutes, the amount of the profits that will be returned into development of other drugs that will save other lives, the baseline cost per life saved across the pharmaceutical industry, et. al.
High prices attract attention to existing social problems and are sometimes useful. Other times they're opportunistic and exploitative. It's not trivial to isolate the two.
Maybe we need a charity that builds a research war chest to threaten companies like this with redevelopment. It costs a lot to replicate a pill and go through the FDA hoops, and once a private company does, the price just gets competed down to the point where it doesn't cover sunk the redevelopment costs--so in some scenarios no one bothers.
Instead, a charity doesn't have to take profit into consideration and can just threaten: drop your price or we'll persue independent redevelopment. With only the credible threat of spending on independent redevelopment, they could devalue a lot of these orphan drugs, and then buy up the rights/trade secrets to them for open release.
Competing businesses can't do this, because they can't pose a credible threat, because following through wouldn't make business sense. A charity can have non-business aims.
[0] http://www.nytimes.com/2012/12/30/business/questcor-finds-pr...
But after your edit - I no longer think that. I just wonder where you got this idea about unbiased or factual journalism. I've never seen it happen, and even if they tried (which they don't), there's always a bias. Personally, I try to read the facts and do my own research on anything I find interesting. Sturgeon's law applies to journalism as well: 90% of everything is crud.
"Mia Brooks of Salmon Arm, B.C., noticed the seizures in her son more than a month ago."
When Mia Brooks of Salmon Arm, B.C. first noticed seizures in her son is completely irrelevant to the subject of the article. I've given my time to read in the hope of forming an educated opinion on a topic of general social interest, and the first thing I encounter after reading a description of the disease is a story meant to induce feelings of sympathy for these unfortunate people. This kind of journalism is, in my opinion, manipulative and socially destructive, no matter how noble its author's intentions. I realize this is a common enough problem, but I don't feel apologetic about pointing out when I see it.
Meanwhile, Questcor and Mallinkodt were/are the poster children for abrupt and unwarranted drug price hikes by orders of magnitude. They are bad actors in an industry where scheming - both legal and otherwise - is so common that no one thinks twice.
Spoken like someone who has never worked on low-volume production before. Fixed costs that amortize to trivial amounts when producing a few million or billion doses a year get significant when amortized across a few thousand.
I don't buy the article's unsourced assertion that the medication only costs $230/dose to make. Assuming 4,000 doses/year (800 patients * 5 doses/patient [$23,000/dose / "over $100,000 per infant"]), that's a production cost of only $920,000. The cost of regulatory compliance alone is probably greater than that.
"When Mallinckrodt acquired Questcor in 2014, Synacthen Depot was one of the products in the portfolio. It was losing money then and still is. Moreover, in the spring of 2014, Mallinckrodt was told by the existing supplier of the product that they would cease production in early 2016," a Mallinckrodt spokesman said in an email to CBC News.
So the company faced an unexpected reduction in supply, and the drug might have been unprofitable at the previous price. One can object to the fact that the means of pharmaceutical production are privately owned, but given that these are not currently non-profit institutions, the outrage seems misplaced. There's nothing "absurd" about it.
Edit:
I'd like to address some of the commenters, who seem to have misinterpreted my comment as a defense of this company, or the pharmaceutical industry in general.
This comment is an objection to the style of journalism in this article: light on information, heavy on emotion. I've said nothing in defense of the corporation.
Some have suggested that these corporations should not increase prices in order to uphold some set of moral principles. I take it for granted that corporations are only answerable to power, and any limitations you might wish to impose upon them must either take the form of collective action (boycotts/protests) or regulation. Perhaps motivating either of these was the intent of the article, but if so the author went about expressing this wish in a way that I find objectionable, by appealing to emotion rather than reason and disguising an ideological belief as factual reporting.